2006
DOI: 10.1186/1471-2377-6-25
|View full text |Cite
|
Sign up to set email alerts
|

Impact of the clinical context on the 14-3-3 test for the diagnosis of sporadic CJD

Abstract: Background: The 14-3-3 test appears to be a valuable aid for the clinical diagnosis of sporadic Creutzfeldt-Jakob disease (sCJD) in selected populations. However, its usefulness in routine practice has been challenged. In this study, the influence of the clinical context on the performance of the 14-3-3 test for the diagnosis of sCJD is investigated through the analysis of a large prospective clinical series.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
22
1

Year Published

2008
2008
2022
2022

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 30 publications
(23 citation statements)
references
References 14 publications
0
22
1
Order By: Relevance
“…The disease related family history is notified in five cases, including the recently reported four German cases belonging to two different families 12 and the first French case whose mother and brother died with dementia and motor impairment without definite diagnosis. 9 Other six cases seem lacking of definite family history. [13][14][15] Onset ages of E196K gCJD range from 64-80 year-old (median: 71 year-old), which are obviously later than that of most other gCJD cases.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The disease related family history is notified in five cases, including the recently reported four German cases belonging to two different families 12 and the first French case whose mother and brother died with dementia and motor impairment without definite diagnosis. 9 Other six cases seem lacking of definite family history. [13][14][15] Onset ages of E196K gCJD range from 64-80 year-old (median: 71 year-old), which are obviously later than that of most other gCJD cases.…”
Section: Discussionmentioning
confidence: 99%
“…CSF 14-3-3 protein was detected with western blot according to the protocol described elsewhere with minor modifications. 9 Briefly, 20 μl CSF sample was separated by 12% SDS-PAGE and electronically transformed onto nitrocellulose membrane. Blots were incubated in 1:1,000 diluted 14-3-3 polyclonal antibodies (Santa Cruz, CA) and further incubated in 1:5,000 diluted HRP-conjugated goat antiRabbit IgG (PerkinElmer, Germany).…”
Section: Discussionmentioning
confidence: 99%
“…However, the amounts of tau isoforms with exon-2 and exon-10 segments in CSF correlate well with positive CSF protein 14-3-3 in the patients of sCJD. 14-3-3 positive in CSF is usually believed as a result of neuronal damage or death [29]. Protein 14-3-3 positive in CSF can be observed in a series of acute brain damage, such as acute cerebral infarction, viral encephalitis, etc.…”
Section: Discussionmentioning
confidence: 99%
“…He developed diffuse spontaneous myoclonus and became increasingly drowsy, then comatose and then died. Autopsy was refused; however, in this setting, the diagnostic certainty of CJD is greater than 90% 9 …”
Section: Casementioning
confidence: 99%
“…Useful clinical tests include electroencephalographic (EEG) indication of periodic sharp‐wave complexes and increased cerebrospinal fluid (CSF) levels of 14‐3‐3 protein, but neither test is specific for CJD 8 . Increased 14‐3‐3 protein levels have a high positive predictive value when clinical suspicion is strong, but are less accurate with decreased pretest diagnostic certainty 9 . Brain biopsy involves risks to both patient and neurosurgeon with the added risk of false‐negative results due to sampling error 10 …”
Section: Introductionmentioning
confidence: 99%